Figure 2
Figure 2. Effects of fucoidan on the maturation of PBDCs. (A) Freshly isolated PBDCs (106) were treated with or without fucoidan (50 μg/mL), LPS (1 μg/mL), or TNF-α (10 ng/mL) for 24 hours as in Figure 1, and the surface expression of CD83, CD80, CD86, or MHC class II on CD11c+ DCs was then measured. (B) CD11chighCD123low mDCs were isolated using a BDCA isolation kit and further purified using a cell sorter and then treated as in panel A. (C) CD1c+ DCs were isolated using a BDCA-1 isolation kit and then treated as in panel A. Data represent the mean ± SD of 3 independent experiments. *P < .01 compared with none. **P < .001 compared with none.

Effects of fucoidan on the maturation of PBDCs. (A) Freshly isolated PBDCs (106) were treated with or without fucoidan (50 μg/mL), LPS (1 μg/mL), or TNF-α (10 ng/mL) for 24 hours as in Figure 1, and the surface expression of CD83, CD80, CD86, or MHC class II on CD11c+ DCs was then measured. (B) CD11chighCD123low mDCs were isolated using a BDCA isolation kit and further purified using a cell sorter and then treated as in panel A. (C) CD1c+ DCs were isolated using a BDCA-1 isolation kit and then treated as in panel A. Data represent the mean ± SD of 3 independent experiments. *P < .01 compared with none. **P < .001 compared with none.

Close Modal

or Create an Account

Close Modal
Close Modal